Solid-state analysis of the active pharmaceutical ingredient in drug products

被引:143
作者
Newman, AW [1 ]
Byrn, SR
机构
[1] SSCI, W Lafayette, IN 47906 USA
[2] Purdue Univ, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/S1359-6446(03)02832-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solid form of a drug substance is important when developing a new chemical entity. The crystalline form used in development is significant based on possible manufacturability, solubility, bioavailability and stability differences between the solid forms. Regulatory issues require that the form present in a solid dosage form or liquids containing undissolved drug substance be identified. Drug product samples can be analyzed by a variety of techniques to determine the crystal form present or changes that occur during the manufacture of a drug product. The form present will affect development, regulatory and intellectual property issues.
引用
收藏
页码:898 / 905
页数:8
相关论文
共 54 条
[11]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[12]  
Byrn S.R., 1999, Solid State Chemistry of Drugs, VSecond
[13]   Chemical reactivity in solid-state pharmaceuticals: formulation implications [J].
Byrn, SR ;
Xu, W ;
Newman, AW .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (01) :115-136
[14]   EFFECT OF MOISTURE ON THE STABILITY OF SOLID DOSAGE FORMS [J].
CARSTENSEN, JT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (14) :1927-1969
[15]  
CHAN HK, 1985, DRUG DEV IND PHARM, V11, P315, DOI 10.3109/03639048509056874
[16]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417
[17]   Quantifying amorphous content of lactose using parallel beam X-ray powder diffraction and whole pattern fitting [J].
Chen, XM ;
Bates, S ;
Morris, KR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (01) :63-72
[18]  
Clarke MJ, 2000, J PHARM SCI, V89, P1160, DOI 10.1002/1520-6017(200009)89:9<1160::AID-JPS8>3.0.CO
[19]  
2-D
[20]   DRUG EXCIPIENT INTERACTION STUDY OF ENALAPRIL MALEATE USING THERMAL-ANALYSIS AND SCANNING ELECTRON-MICROSCOPY [J].
COTTON, ML ;
WU, DW ;
VADAS, EB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 40 (1-2) :129-142